Health product recall

Accupril Tabs: Nitrosamine impurity

Last updated

Summary

Product
Accupril Tabs
Issue
Health products - Contamination
What to do

See instructions below. 

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Accupril Tabs Accupril Tab 10mg DIN 01947672 Tablet QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 10mg DY3042, CK5285
Accupril Tabs Accupril Tab 20mg DIN 01947680 Tablet QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 20mg DT9592, CK6258, CK6259
Accupril Tabs Accupril Tab 40mg DIN 01947699 Tablet QUINAPRIL (QUINAPRIL HYDROCHLORIDE), 40mg DT9591, CM2828, CM2829

Issue

Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.

What you should do

  • Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.
  • Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.
  • If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries.
  • Report any health product-related side effects or complaints to Health Canada.

Additional information

Previous recalls or alerts
Background

Depth of recall: Retailers 

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Pfizer Canada ULC.

17300 Trans-Canada Highway,

Kirkland, QC,

H9J 2M5

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-64095